Index
1 Interleukin 17A Market Overview
1.1 Product Overview and Scope of Interleukin 17A
1.2 Interleukin 17A Segment by Type
1.2.1 Global Interleukin 17A Market Value Comparison by Type (2024-2030)
1.2.2 ABY-035
1.2.3 CNTO-6785
1.2.4 DLX-2882
1.2.5 Others
1.3 Interleukin 17A Segment by Application
1.3.1 Global Interleukin 17A Market Value by Application: (2024-2030)
1.3.2 Chronic Pain
1.3.3 Liver Cancer
1.3.4 Kidney Cancer
1.3.5 Others
1.4 Global Interleukin 17A Market Size Estimates and Forecasts
1.4.1 Global Interleukin 17A Revenue 2019-2030
1.4.2 Global Interleukin 17A Sales 2019-2030
1.4.3 Global Interleukin 17A Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Interleukin 17A Market Competition by Manufacturers
2.1 Global Interleukin 17A Sales Market Share by Manufacturers (2019-2024)
2.2 Global Interleukin 17A Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Interleukin 17A Average Price by Manufacturers (2019-2024)
2.4 Global Interleukin 17A Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Interleukin 17A, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Interleukin 17A, Product Type & Application
2.7 Interleukin 17A Market Competitive Situation and Trends
2.7.1 Interleukin 17A Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Interleukin 17A Players Market Share by Revenue
2.7.3 Global Interleukin 17A Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Interleukin 17A Retrospective Market Scenario by Region
3.1 Global Interleukin 17A Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Interleukin 17A Global Interleukin 17A Sales by Region: 2019-2030
3.2.1 Global Interleukin 17A Sales by Region: 2019-2024
3.2.2 Global Interleukin 17A Sales by Region: 2025-2030
3.3 Global Interleukin 17A Global Interleukin 17A Revenue by Region: 2019-2030
3.3.1 Global Interleukin 17A Revenue by Region: 2019-2024
3.3.2 Global Interleukin 17A Revenue by Region: 2025-2030
3.4 North America Interleukin 17A Market Facts & Figures by Country
3.4.1 North America Interleukin 17A Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Interleukin 17A Sales by Country (2019-2030)
3.4.3 North America Interleukin 17A Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Interleukin 17A Market Facts & Figures by Country
3.5.1 Europe Interleukin 17A Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Interleukin 17A Sales by Country (2019-2030)
3.5.3 Europe Interleukin 17A Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Interleukin 17A Market Facts & Figures by Country
3.6.1 Asia Pacific Interleukin 17A Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Interleukin 17A Sales by Country (2019-2030)
3.6.3 Asia Pacific Interleukin 17A Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Interleukin 17A Market Facts & Figures by Country
3.7.1 Latin America Interleukin 17A Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Interleukin 17A Sales by Country (2019-2030)
3.7.3 Latin America Interleukin 17A Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Interleukin 17A Market Facts & Figures by Country
3.8.1 Middle East and Africa Interleukin 17A Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Interleukin 17A Sales by Country (2019-2030)
3.8.3 Middle East and Africa Interleukin 17A Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Interleukin 17A Sales by Type (2019-2030)
4.1.1 Global Interleukin 17A Sales by Type (2019-2024)
4.1.2 Global Interleukin 17A Sales by Type (2025-2030)
4.1.3 Global Interleukin 17A Sales Market Share by Type (2019-2030)
4.2 Global Interleukin 17A Revenue by Type (2019-2030)
4.2.1 Global Interleukin 17A Revenue by Type (2019-2024)
4.2.2 Global Interleukin 17A Revenue by Type (2025-2030)
4.2.3 Global Interleukin 17A Revenue Market Share by Type (2019-2030)
4.3 Global Interleukin 17A Price by Type (2019-2030)
5 Segment by Application
5.1 Global Interleukin 17A Sales by Application (2019-2030)
5.1.1 Global Interleukin 17A Sales by Application (2019-2024)
5.1.2 Global Interleukin 17A Sales by Application (2025-2030)
5.1.3 Global Interleukin 17A Sales Market Share by Application (2019-2030)
5.2 Global Interleukin 17A Revenue by Application (2019-2030)
5.2.1 Global Interleukin 17A Revenue by Application (2019-2024)
5.2.2 Global Interleukin 17A Revenue by Application (2025-2030)
5.2.3 Global Interleukin 17A Revenue Market Share by Application (2019-2030)
5.3 Global Interleukin 17A Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie Inc
6.1.1 AbbVie Inc Corporation Information
6.1.2 AbbVie Inc Description and Business Overview
6.1.3 AbbVie Inc Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Inc Interleukin 17A Product Portfolio
6.1.5 AbbVie Inc Recent Developments/Updates
6.2 Abeome Corporation
6.2.1 Abeome Corporation Corporation Information
6.2.2 Abeome Corporation Description and Business Overview
6.2.3 Abeome Corporation Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abeome Corporation Interleukin 17A Product Portfolio
6.2.5 Abeome Corporation Recent Developments/Updates
6.3 Affibody AB
6.3.1 Affibody AB Corporation Information
6.3.2 Affibody AB Description and Business Overview
6.3.3 Affibody AB Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Affibody AB Interleukin 17A Product Portfolio
6.3.5 Affibody AB Recent Developments/Updates
6.4 Cell Medica Limited
6.4.1 Cell Medica Limited Corporation Information
6.4.2 Cell Medica Limited Description and Business Overview
6.4.3 Cell Medica Limited Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cell Medica Limited Interleukin 17A Product Portfolio
6.4.5 Cell Medica Limited Recent Developments/Updates
6.5 Eli Lilly and Company
6.5.1 Eli Lilly and Company Corporation Information
6.5.2 Eli Lilly and Company Description and Business Overview
6.5.3 Eli Lilly and Company Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eli Lilly and Company Interleukin 17A Product Portfolio
6.5.5 Eli Lilly and Company Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Johnson & Johnson Interleukin 17A Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Merck KGaA
6.6.1 Merck KGaA Corporation Information
6.6.2 Merck KGaA Description and Business Overview
6.6.3 Merck KGaA Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck KGaA Interleukin 17A Product Portfolio
6.7.5 Merck KGaA Recent Developments/Updates
6.8 Novartis AG
6.8.1 Novartis AG Corporation Information
6.8.2 Novartis AG Description and Business Overview
6.8.3 Novartis AG Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Novartis AG Interleukin 17A Product Portfolio
6.8.5 Novartis AG Recent Developments/Updates
6.9 Orega Biotech SAS
6.9.1 Orega Biotech SAS Corporation Information
6.9.2 Orega Biotech SAS Description and Business Overview
6.9.3 Orega Biotech SAS Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Orega Biotech SAS Interleukin 17A Product Portfolio
6.9.5 Orega Biotech SAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Interleukin 17A Industry Chain Analysis
7.2 Interleukin 17A Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Interleukin 17A Production Mode & Process
7.4 Interleukin 17A Sales and Marketing
7.4.1 Interleukin 17A Sales Channels
7.4.2 Interleukin 17A Distributors
7.5 Interleukin 17A Customers
8 Interleukin 17A Market Dynamics
8.1 Interleukin 17A Industry Trends
8.2 Interleukin 17A Market Drivers
8.3 Interleukin 17A Market Challenges
8.4 Interleukin 17A Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer